|
DCAF10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63256083599117E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.09869940607177E-11 |
| Normal-vs-Stage2 |
1.378000E-04 |
| Normal-vs-Stage3 |
2.29839480780925E-11 |
| Normal-vs-Stage4 |
5.16340303846619E-11 |
| Stage1-vs-Stage2 |
3.920200E-01 |
| Stage1-vs-Stage3 |
5.004100E-02 |
| Stage1-vs-Stage4 |
3.889700E-02 |
| Stage2-vs-Stage3 |
5.103800E-02 |
| Stage2-vs-Stage4 |
2.882300E-02 |
| Stage3-vs-Stage4 |
6.075600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11559675228546E-13 |
| Normal-vs-AfricanAmerican |
2.388200E-04 |
| Normal-vs-Asian |
8.15790002217653E-09 |
| Caucasian-vs-AfricanAmerican |
5.620600E-01 |
| Caucasian-vs-Asian |
6.723000E-01 |
| AfricanAmerican-vs-Asian |
4.230000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.08970005136189E-09 |
| Normal-vs-Female |
3.0820901386619E-12 |
| Male-vs-Female |
9.373000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.52700002537176E-09 |
| Normal-vs-Age(41-60Yrs) |
1.66260338829716E-11 |
| Normal-vs-Age(61-80Yrs) |
1.07849995600873E-09 |
| Normal-vs-Age(81-100Yrs) |
1.602580E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.789380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.477600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.580600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.860800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.592400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.333200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.938000E-02 |
| Classical-VS-Follicular |
1.846800E-01 |
| Classical-VS-Other |
3.005600E-01 |
| Classical-VS-Normal |
1.99069649653438E-11 |
| Tall-VS-Follicular |
8.859800E-03 |
| Tall-VS-Other |
9.073800E-01 |
| Tall-VS-Normal |
1.16060000499019E-08 |
| Follicular-VS-Other |
1.895380E-01 |
| Follicular-VS-Normal |
1.62803999999017E-05 |
| Other-VS-Normal |
8.628500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.32119989895807E-10 |
| Normal-vs-N1 |
4.11700007418858E-10 |
| N0-vs-N1 |
1.478250E-01 |
|
|
